Global Psoriatic Arthritis Market to Rise at a Moderate CAGR of Nearly 5% by 2019
ResearchMoz added Latest Research Report titled " Global Psoriatic Arthritis Market 2015-2019: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.
Albany, NY -- (SBWire) -- 06/01/2016 --Psoriatic arthritis is a chronic inflammatory disease that affects the distal joints in the body and may also affect the back and sacroiliac joints of the pelvis. The global market for psoriatic arthritis is expected to witness moderate growth during the forecast period and factors like the increase in penetration of biologic therapies are expected to augment the prospects for growth in this market. Additionally, the recent launch of products like Otezla and Stelara is also expected to boost market growth during the forecast period, resulting in its moderate CAGR of nearly 5% by 2019.
In this market research report, Technavio analysts estimate the Americas to account for more than 40% of the total market share by 2019. High market dominion of this region can be attributed to factors such as the increase in public awareness and the growing preference for biologic drugs.
Segmentation by mechanism of action and analysis of: TNF inhibitors, PDE4 inhibitors, & interleukin blockers
The TNF inhibitors aid in suppressing the inflammatory response in the patient's body. These inhibitors are used to manage diseases like rheumatoid arthritis, psoriatic arthritis, psoriasis, inflammatory bowel disease, and seronegative spondyloarthropathies. Moreover, its ability to use a targeted mechanism to treat most of the inflammatory and autoimmune diseases is primarily responsible for its high market share of almost 80% by 2019.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=494445
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
- TNF inhibitors
- PDE4 inhibitors
- Interleukin blockers
- Others
Segmentation by type of disease and analysis of: mild, moderate, & severe psoriatic arthritis -
The mild psoriatic arthritis segment accounts for more than 60% of all the diagnosed cases and is the most common type of psoriatic arthritis in patients across the globe. This condition affects less than four joints in the body and is also known as oligoarticular arthritis.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
- Mild psoriatic arthritis
- Moderate psoriatic arthritis
- Severe psoriatic arthritis
Competitive landscape and key vendors: Abbvie, Amgen, Janssen Pharmaceuticals -
This market is primarily dominated by large vendors due to their extensive product portfolios. The company that manufactures and markets a drug that can treat psoriatic arthritis, and also exhibit a high safety and efficacy profile, is expected to gain a competitive advantage over its rivals during the forecast period.
Leading vendors in this market are -
- Abbvie
- Amgen
- Janssen Pharmaceuticals
- Celgene
- UCB
Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=494445
Key questions answered in the report include -
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the psoriatic arthritis market?
- What are the key market trends impacting the growth of the psoriatic arthritis market?
- What are the challenges to market growth?
- Who are the key vendors in the psoriatic arthritis market?
- What are the market opportunities and threats faced by the vendors in the psoriatic arthritis market?
- Trending factors influencing the market shares of APAC, EMEA, and the Americas?
- What are the key outcomes of the five forces analysis of the psoriatic arthritis market?
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Media Relations Contact
Mr. Nachiket
Manager
Researchmoz Global Pvt. Ltd.
1-518-621-2074
http://www.researchmoz.us/
View this press release online at: http://rwire.com/694496